Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-8 of 8
Keywords: Oral chemotherapy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Errors and Nonadherence in Pediatric Oral Chemotherapy Use
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2016) 91 (4): 231–236.
Published Online: 03 August 2016
...Kathleen Walsh; Jamie Ryan; Nancy Daraiseh; Ahna Pai Background: Nonadherence and medication error both limit the effectiveness of oral chemotherapy. The overlap between nonadherence and medication error is not well studied in children, and interventions strategies differ for each. Our objective...
Journal Articles
Adherence and Patients' Attitudes to Oral Anticancer Drugs: A Prospective Series of 201 Patients Focusing on Targeted Therapies
Available to PurchaseSubject Area:
Oncology
Philippe Barthélémy, Irène Asmane-De la Porte, Nicolas Meyer, Brigitte Duclos, Sebastian Serra, Louis-Marie Dourthe, Shanti Amé, Valère Litique, Cathy Giron, Veronica Goldbarg, Luc Fornecker, Elisabeth Quoix, Jean-Emmanuel Kurtz
Journal:
Oncology
Oncology (2014) 88 (1): 1–8.
Published Online: 18 September 2014
...). Treatment was prescribed in the neoadjuvant/adjuvant or advanced setting in 18 and 69% of cases, respectively, whereas hematologic malignancies for which this criterion is not applicable accounted for 13%. We identified 99 patients taking oral chemotherapy or hormone therapy (HC group), whereas 102 took TT...
Journal Articles
Combination of Idarubicin and Cyclophosphamide Administered Orally in Untreated Postmenopausal Breast Cancer Patients: A Phase II Study
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (1991) 48 (2): 93–96.
Published Online: 26 June 2009
.... 26 6 2009 4-Demethoxydaunorubicin Cyclophosphamide Oral chemotherapy Breast cancer © 1991 S. Karger AG, Basel 1991 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized...
Journal Articles
Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
Available to PurchaseSubject Area:
Oncology
Maria S. Pino, Michele Milella, Alain Gelibter, Isabella Sperduti, Salvatore De Marco, Carmen Nuzzo, Emilio Bria, Livio Carpanese, Enzo M. Ruggeri, Paolo Carlini, Francesco Cognetti
Journal:
Oncology
Oncology (2009) 76 (4): 254–261.
Published Online: 26 February 2009
... Oral chemotherapy Cyclooxygenase-2 (COX-2), the inducible enzyme catalyzing the rate-limiting step in the conversion of arachidonic acid into prostaglandins and other eicosanoids, has recently emerged as a potential pharmacological target for inhibiting tumor growth [ 18 ]. Indeed...
Journal Articles
UFT as Maintenance Therapy in Patients with Advanced Colorectal Cancer Responsive to the FOLFOX4 Regimen
Available to PurchaseSubject Area:
Oncology
R. Scalamogna, S. Brugnatelli, C. Tinelli, P. Sagrada, E. Gattoni, M.C. Tronconi, A. Riccardi, G. Luchena, G.R. Corazza
Journal:
Oncology
Oncology (2008) 72 (5-6): 267–273.
Published Online: 11 January 2008
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 5-Fluorouracil FOLFOX4 Metastatic colorectal cancer Oral chemotherapy Oxaliplatin Quality of life SF-36 questionnaire UFT Colorectal...
Journal Articles
Oral Doxifluridine in Advanced Hepatocellular Carcinoma: A Phase II Study
Available to PurchaseSubject Area:
Oncology
Monica Lencioni, Alfredo Falcone, Giacomo Allegrini, Elisabetta Pfanner, Gianluca Masi, Isa Brunetti, Roberta Di Marsico, Eloise Fontana, Cinzia Orlandini, Corrado Gallo Stampino, Carlo Bartolozzi, Pier Franco Conte
Journal:
Oncology
Oncology (2000) 59 (3): 204–209.
Published Online: 02 October 2000
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Doxifluridine Hepatocellular carcinoma Oral chemotherapy Phase II...
Journal Articles
Fluoropyrimidines: A Critical Evaluation
Available to PurchaseSubject Area:
Oncology
Rogelio A. Brito, Diana Medgyesy, Thomas H. Zukowski, Melanie E Royce, Farhad Ravandi-Kashani, Paulo M. Hoff, Richard Pazdur
Journal:
Oncology
Oncology (1999) 57 (Suppl. 1): 2–8.
Published Online: 21 July 1999
... Colon cancer Fluoropyrimidines 5-FU UFT S-1 Xeloda ® (capecitabine) Emitefur Eniluracil Oral chemotherapy 5-FU has been studied in several different dosing regimens, including a daily bolus schedule for five consecutive days, weekly bolus schedules and continuous infusions extending...
Journal Articles
Rational Design of New Tumoractivated TM Cytotoxic Agents
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (1999) 57 (Suppl. 1): 9–15.
Published Online: 21 July 1999
..., instructions or products referred to in the content or advertisements. Xeloda ® (capecitabine) 5-Fluorouracil Fluoropyrimidines Solid tumors Tumor-selective activation Oral chemotherapy 5-Fluorouracil (5-FU) is one of the most frequently used cytotoxic agents for the treatment of solid...